fully cashed up biotech, page-5

Agreed. I'm happy to sit on it for years. I think we'll know by next year how the company is sitting in terms of deals though. By then, the lenses should be in the market (development results pending) and most R&D deals will have been completed with licenses entered into. I think we should have a clearer picture about the company's future then (to state the obvious).

The important thing, and this is why I'm happy to be in it, is that it has superior technology (in that it has almost zero chance of resistance being developed and is biodegradable), a gun team of scientists, all the right contacts and a global market worth squillions. If you were ever going to take a risk on a biotech, well...

C'mon end of march results!!